Showing results (21-30 of 183) with videos related to
Sort By:
Pageof 19
Expert Review of Hematology|January 8, 2025
Characterizing the ideal patient for treatment with inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: a systematic literature reviewDavid I Marks, Ryan D Cassaday, Josep-Maria Ribera, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 5, 2020
BEAM-Campath Allogeneic Stem Cell Transplant for Patients with Relapsed/Refractory Lymphoma: High Incidence of Long-Term Mixed Donor-Recipient Chimerism and the Response to Donor Lymphocyte InfusionsClaire Burney, Karan Wadhera, Patricia Breslin, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 1, 2006
The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapyGordon Cook, Richard E Clark, Charles Crawley, et al.British Journal of Haematology|August 30, 2002
The impact of transfusion of leucodepleted platelet concentrates on cytomegalovirus disease after allogeneic stem cell transplantationMilind D Ronghe, Annabel B M Foot, Jaqueline M Cornish, et al.Multiple Sclerosis and Related Disorders|April 9, 2022
Repeat infusion of autologous bone marrow cells in progressive multiple sclerosis - A phase I extension study (SIAMMS II)Claire M Rice, Pamela Sarkar, Peter Walsh, et al.Cancer Medicine|August 23, 2019
Burden of hospitalization in acute lymphoblastic leukemia patients treated with Inotuzumab Ozogamicin versus standard chemotherapy treatmentDavid I Marks, Ilse van Oostrum, Sabrina Mueller, et al.Hematology (Amsterdam, Netherlands)|July 12, 2008
The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation studyMaria H Gilleece, Rachel Pearce, David C Linch, et al.Cancer|August 2, 2024
Inotuzumab ozogamicin in adult acute lymphoblastic leukemia: Development, current status, and future directionsHagop M Kantarjian, Nicolas Boissel, Cristina Papayannidis, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2014
Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation practice guideline committeeJoseph Bubalo, Paul A Carpenter, Navneet Majhail, et al.BMJ Open|September 13, 2015
Repeat infusion of autologous bone marrow cells in multiple sclerosis: protocol for a phase I extension study (SIAMMS-II)Claire M Rice, David I Marks, Peter Walsh, et al.Pageof 19